Methodological issues in the use of composite endpoints in clinical trials: examples from the HIV field

Composite Outcomes in Cardiovascular Research: A Survey of Randomized Trials

(2013) Eric Lim et al.   ANNALS OF INTERNAL MEDICINE

Induction therapy with trizivir plus efavirenz or lopinavir/ritonavir followed by trizivir alone in naive HIV-1-infected adults

(2009) Josep Mallolas et al.   AIDS

Efficacy and tolerability of long-term efavirenz plus nucleoside reverse transcriptase inhibitors for HIV-1 infection

(2009) Karen Tashima et al.   AIDS

Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients

(2009) Jean-François Delfraissy et al.   AIDS

Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV

(2009) Federico Pulido et al.   AIDS

Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy

(2009) Benoît Marin et al.   AIDS

Designing and interpreting HIV noninferiority trials in naive and experienced patients

(2008) Andrew Hill et al.   AIDS

British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008

(2008) BG Gazzard et al.   HIV MEDICINE

Antiretroviral Treatment of Adult HIV Infection

(2008) Scott M. Hammer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Class-Sparing Regimens for Initial Treatment of HIV-1 Infection

(2008) Sharon A. Riddler et al.   NEW ENGLAND JOURNAL OF MEDICINE